Article
Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases.
International journal of clinical oncology - 1 Feb 2014
Kaneko Yuka, Kuramochi Hidekazu, Nakajima Go, Inoue Yuji, Yamamoto Masakazu
Abstract excerpt
BACKGROUND: KRAS mutation is widely accepted as a strong, negative predictive marker for anti-epidermal growth factor receptor antibodies, including cetuximab and panitumumab. Previous reports demonstrated approximately 100 % concordance of KRAS status between primary colorectal cancer and liver metastases; however, mismatched KRAS status still occurs. METHODS: KRAS status was evaluated in 105 pairs of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
